Targeting heparin and heparan sulfate protein interactions.
Ryan J WeissJeffrey D EskoYitzhak TorPublished in: Organic & biomolecular chemistry (2017)
Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars. Unlike heparin, which is only found in mast cells, heparan sulfate is ubiquitously expressed on the cell surface and in the extracellular matrix of all animal cells. These negatively-charged glycans play essential roles in important cellular functions such as cell growth, adhesion, angiogenesis, and blood coagulation. These biomolecules are also involved in pathophysiological conditions such as pathogen infection and human disease. This review discusses past and current methods for targeting these complex biomolecules as a novel therapeutic strategy to treating disorders such as cancer, neurodegenerative diseases, and infection.
Keyphrases
- cell surface
- extracellular matrix
- venous thromboembolism
- endothelial cells
- growth factor
- induced apoptosis
- cancer therapy
- papillary thyroid
- cell cycle arrest
- squamous cell carcinoma
- vascular endothelial growth factor
- squamous cell
- candida albicans
- cell death
- drug delivery
- lymph node metastasis
- pseudomonas aeruginosa
- cystic fibrosis
- wound healing
- pi k akt